Endogenous / BiologyEndogenousHuman-supportedUpdated 2026-04-24

Peptide reference file

Kisspeptin

Trending #22 in Endogenous8.4k searches/moProven

Kisspeptin is an endogenous neuropeptide that regulates reproductive-axis signaling through effects on GnRH pathways.

Current readout: human-supported evidence, endogenous status, endogenous approval state, human evidence appears in the current trail, registered trials are linked, and 3 linked sources in the seed trail.

PubChem CID 71306396 | 3408 PubMed results | 36 trial records | 0 DailyMed labels | 0 Drugs@FDA applications

Kisspeptin is mostly discussed because it is an important peptide if you want to understand reproductive-axis biology beyond older GnRH analogs.

The public claim is straightforward: It is an important peptide if you want to understand reproductive-axis biology beyond older GnRH analogs. Strong biology and meaningful human endocrine relevance.

In plain language, kisspeptin is an endogenous neuropeptide that regulates reproductive-axis signaling through effects on GnRH pathways.

Human-supportedEndogenous
Reproductive axisGnRH signalingNeuroendocrine control

Aliases: KISS1 peptide, Metastin

SpecimenKisspeptin specimen
CCCCCHHHHHHHNO
Formula
C258H401N79O78
Mass
5857
Evidence
Human-supported
Elements
4

Most commonly discussed in relation to Reproductive axis, GnRH signaling, Neuroendocrine control.

What Kisspeptin is

Kisspeptin is an endogenous neuropeptide that regulates reproductive-axis signaling through effects on GnRH pathways.

Kisspeptin is grouped under Endogenous / Biology / Approved / Clinical on PeptideFactCheck because it is an important peptide if you want to understand reproductive-axis biology beyond older GnRH analogs.

The useful starting point is to separate the molecule itself from the internet story around it. It is an important peptide if you want to understand reproductive-axis biology beyond older GnRH analogs.

Why people keep looking it up

It is an important peptide if you want to understand reproductive-axis biology beyond older GnRH analogs.

Kisspeptin is an endogenous neuropeptide that regulates reproductive-axis signaling through effects on GnRH pathways.

Kisspeptin tends to stay in the conversation because it touches a familiar public theme: reproductive axis, gnrh signaling, and neuroendocrine control. That makes it easy for the claim to travel faster than the evidence.

What the evidence can support right now

Strong biology and meaningful human endocrine relevance.

Human physiology and clinical investigation exist, especially in reproductive-endocrine contexts.

Mechanistic support around GnRH control and reproductive-axis signaling is strong.

Why this page carries the current tier: Strong biology and meaningful human endocrine relevance.

The current seed trail for Kisspeptin is pulling from 2 databases sources and 1 literature source.

Safety, limits, and regulatory context

Reproductive endocrine signaling should not be flattened into casual optimization language.

Kisspeptin is tracked here as endogenous biology rather than an FDA-approved peptide drug.

Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for Kisspeptin. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.

Molecular and identifier data

The current PubChem match for Kisspeptin is CID 71306396. That gives the page a source-backed chemistry record rather than a placeholder identifier block.

PubChem CID
71306396
Formula
C258H401N79O78
Molecular weight
5857
InChIKey
KAHDONZOCXSKII-NJVVDGNHSA-N

Matched synonyms include Kisspeptin, Kisspeptins, KISS-1, KISS-1 metastasis suppressor, Metastin, 388138-21-4, 2VG74ZW2K5, DTXSID00192075.

Open PubChem record

Clinical trial snapshot

The current ClinicalTrials.gov intervention query for Kisspeptin returns 36 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.

Literature snapshot

The current PubMed query for Kisspeptin returns 3408 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.

Source trail

Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.

Safety noteThis content is educational only and does not replace medical advice. Peptide use may carry risks and should be discussed with a qualified medical professional.